blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3824879

EP3824879 - A STABLE LIQUID FORMULATION OF FUSION PROTEIN WITH IGG FC DOMAIN [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  27.06.2024
Database last updated on 31.08.2024
FormerExamination is in progress
Status updated on  01.04.2022
FormerRequest for examination was made
Status updated on  23.04.2021
Most recent event   Tooltip11.07.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Alteogen Inc.
62 Yuseong-daero 1628beon-gil
Yuseong-gu
Daejeon 34054 / KR
[2021/21]
Inventor(s)01 / PARK, Soon Jae
62, Yuseong-daero 1628beon-gil
Yuseong-gu Daejeon 34054 / KR
02 / CHUNG, Hye Shin
62, Yuseong-daero 1628beon-gil
Yuseong-gu Daejeon 34054 / KR
03 / KIM, Jun Young
62, Yuseong-daero 1628beon-gil
Yuseong-gu Daejeon 34054 / KR
 [2021/21]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2021/21]
Application number, filing date20195634.923.06.2016
[2021/21]
Priority number, dateKR2015008918623.06.2015         Original published format: KR 20150089186
KR2016007823422.06.2016         Original published format: KR 20160078234
[2021/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3824879
Date:26.05.2021
Language:EN
[2021/21]
Search report(s)(Supplementary) European search report - dispatched on:EP23.04.2021
ClassificationIPC:A61K9/08, A61K47/18, A61K47/26, A61K38/17, A61K39/395
[2021/21]
CPC:
C07K14/71 (EP,US); A61K47/6845 (RU); A61K9/08 (CN,KR);
A61K38/179 (EP,CN,KR,US); A61K39/395 (CN); A61K47/18 (RU);
A61K47/183 (EP,CN,US); A61K47/22 (KR); A61K47/26 (EP,CN,KR,RU,US);
A61K9/00 (RU); A61K9/0019 (EP,CN,KR,US); A61K9/0048 (CN,KR);
A61P27/02 (CN,KR); C07K2319/30 (EP,US) (-)
C-Set:
A61K38/179, A61K2300/00 (CN);
A61K39/395, A61K2300/00 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/21]
TitleGerman:STABILE FLÜSSIGE FORMULIERUNG VON FUSIONSPROTEIN MIT IGG-FC-DOMÄNE[2021/21]
English:A STABLE LIQUID FORMULATION OF FUSION PROTEIN WITH IGG FC DOMAIN[2021/21]
French:FORMULE LIQUIDE STABLE D'UNE PROTÉINE DE FUSION PRÉSENTANT UN DOMAINE FC D'IGG[2021/21]
Examination procedure09.10.2020Examination requested  [2021/21]
25.11.2021Amendment by applicant (claims and/or description)
14.12.2021Observations by third parties
31.03.2022Despatch of a communication from the examining division (Time limit: M04)
08.08.2022Reply to a communication from the examining division
02.12.2022Despatch of a communication from the examining division (Time limit: M04)
12.04.2023Reply to a communication from the examining division
05.06.2024Date of oral proceedings
27.06.2024Minutes of oral proceedings despatched
12.07.2024Communication of intention to grant the patent
Parent application(s)   TooltipEP16814702.3  / EP3313373
Fees paidRenewal fee
09.10.2020Renewal fee patent year 03
09.10.2020Renewal fee patent year 04
09.10.2020Renewal fee patent year 05
05.11.2021Renewal fee patent year 06
29.06.2022Renewal fee patent year 07
28.06.2023Renewal fee patent year 08
24.06.2024Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.06.202106   M06   Fee paid on   05.11.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2006217311  (DIX DANIEL [US], et al);
 [I]US2015017163  (PATEL SAMIR [US], et al)
by applicantWO2007149334
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.